Onconetix (ONCO) EBITDA Margin (2024 - 2026)
Onconetix (ONCO) recorded EBITDA Margin of -15935.50% in Q2 2026, down 14121.58 percentage points from -1813.92% a year earlier but up 31696.52 percentage points from the prior quarter.
Powered by 
Analysis
Onconetix (ONCO) EBITDA Margin (2024 - 2026) Analysis & Trends
On a TTM basis, Onconetix's EBITDA Margin came in at -2522.74% as of Jun 30, 2026, up 941.29 percentage points year-over-year; for FY2025, it came in at -2188.17%, up 20.82 percentage points from FY2024.
- Across earlier years, EBITDA Margin came in at -2208.99% in FY2024 (+59350.34 pp) and -61559.32% in FY2023.
- Quarterly EBITDA Margin has ranged from -47632.02% in Q1 2026 to -420.96% in Q4 2025 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in two of the last six quarters, with an average year-over-year change of -9422.67 percentage points.
- Per Business Quant, the preceding three quarters came in at -47632.02% (Q1 2026), -420.96% (Q4 2025) and -680.34% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.68 Bn | 229.71 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 177.86 Bn | 148.29 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 161.61 Bn | 145.42 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 154.33 Bn | 134.62 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 122.70 Bn | 87.95 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 117.16 Bn | 103.27 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 67.25 Bn | 62.02 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 54.64 Bn | 51.79 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 51.63 Bn | 35.64 Bn | 1.35 Bn | 31.93% |
| 10 | Onconetix | 915,498.70 | -14.80 Mn | 4,303.00 | -15,935.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,935.50% |
| Mar 31, 2026 | -47,632.02% |
| Dec 31, 2025 | -419.67% |
| Sep 30, 2025 | -642.40% |
| Jun 30, 2025 | -1,813.92% |
| Mar 31, 2025 | -12,359.65% |
| Dec 31, 2024 | -4,076.90% |
| Sep 30, 2024 | -574.07% |
| Jun 30, 2024 | -1,887.33% |
| Mar 31, 2024 | -1,526.54% |
API Access
Onconetix EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ONCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ONCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ONCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();